Navigation Links
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Date:3/27/2008

r. Optimised for extended serum half-life, PRS-050 exhibits comparable binding and functional in vitro activity to approved VEGF antagonists. Potent inhibition of VEGF-induced enhanced vascular permeability and angiogenesis, as well as anti-tumour activity, have already been demonstrated for PRS-050 in various well-validated in vivo preclinical studies.

As a next generation VEGF antagonist, PRS-050 exploits several favourable characteristics of Anticalins(R), including compact protein structure, high intrinsic stability, broad formulation flexibility and small molecular size with the potential to penetrate neovascularized tumour tissue more effectively. PRS-050 is currently being prepared for a Phase I study in patients with advanced malignancies.

Further information on Pieris AG is available at http://www.pieris-ag.com

Anticalin(R) and Duocalin(R) are registered trademarks of Pieris AG.

About OrbiMed Advisors, LLC

OrbiMed is a preeminent asset management firm focused on the global health sciences industry, with over $6 billion in assets under management across a family of venture capital funds, hedge funds and other investment vehicles. OrbiMed's investment advisory activities were founded in 1989 by Samuel D. Isaly, with a vision to invest across the spectrum of healthcare companies from small privately-held firms to large multinational companies.

OrbiMed's investment team includes over 20 experienced professionals with backgrounds in science, medicine, finance and law. OrbiMed's professionals work together in a collaborative, team-oriented approach. OrbiMed seeks to be the capital provider of choice for life sciences companies pursuing growth and new opportunities. Where appropriate, particularly within its venture capital activities, OrbiMed supports its invested companies in achieving strategic, financial and operational objectives via participation at the Board of Di
'/>"/>

SOURCE Pieris AG
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Pieris Validates the Use of Anticalins(R) as Ophthalmologic Biotherapeutics
2. Moodys Raises Rating for Gerresheimer
3. SleepQuest Raises Awareness of Sleep Disorders
4. Arthrosurface Raises $4 Million of Preferred Equity Financing
5. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
6. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
7. Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding
8. Primera Biosystems Raises $21 Million in Series B Private Round
9. Cellectar, Inc. Raises $13 Million in Private Offering
10. Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
11. Anesiva Raises $45 Million in Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Earlier this year, Google announced the ... As this directly impacts the core component of the product, ... the most sweeping updates since its inception in October of ... posted a very informative article on the subject.. ... date for enhanced campaigns . Only recently, a ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 NuView Life ... imaging and in vitro diagnostic (IVD) biomarkers, today announced ... novel urine screen in development for the early detection ... presented in an oral presentation at the 2013 Annual ... Imaging (SNMMI) in Vancouver, Canada on Sunday, June 9th. ...
(Date:6/17/2013)... 17, 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: ... R. Joseph as Chief Legal Officer.  Mr. Joseph ... experience and has worked in both public and private ... (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ) ... a general counsel and senior executive and his knowledge ...
(Date:6/17/2013)... zuChem Inc., a leading producer of ... today that the United States Patent and Trademark ... 8,367,346 entitled “Methods for Production of Xylitol in ... D-Mannitol." These two patents expand zuChem's technology portfolio ... products from abundant, renewable feedstocks. , The ...
Breaking Biology Technology:Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 2Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 3NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4zuChem Receives Two Polyol Patents 2
... -... -- DALLAS, Texas, September 3, 2010 ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... , Sept. 2 For marketers everywhere, especially consumer ... of success, the question asked has now been definitively ... Scientist approached NeuroFocus to test three different cover designs ... crystallized what marketers around the globe want to know. ...
... RALEIGH, N.C., Sept. 2 Sicel Technologies, Inc., ... placed into involuntary bankruptcy. Effective August 31, 2010, ... interim Director of the company. Currently, Sicel,s operations ... been furloughed have returned to work.Media Contact: Lisa ...
Cached Biology Technology:New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 2New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 3New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 4New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 5New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 6New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 7New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 8Sales Success Shows Neuromarketing Moves Magazines: New Scientist Reports 12% Increase in Newsstand Sales for Issue Featuring NeuroFocus-Tested Cover Design 2Sales Success Shows Neuromarketing Moves Magazines: New Scientist Reports 12% Increase in Newsstand Sales for Issue Featuring NeuroFocus-Tested Cover Design 3
(Date:6/18/2013)... Council, Laboratory of Molecular Biology, has been honored ... Investigator Award. Torrent is being recognized for his ... to predict antimicrobial regions in proteins. Luis Rivas, ... applying this algorithm to interrogate full genomes in ... very appealing results." , Torrent obtained his ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... nervous system infections may well be suffering from the ... study to be published in mBio , the ... Researchers have detected the virus in spinal fluid from ... infections of unknown cause, and in an average of ... suggesting animals may serve as reservoirs for transmission to ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... fruit tree grown in most Mediterranean-type climates. Although some ... species on earth, global expansion of fig crops has ... production practices and the limited number of fig cultivars ... the Mediterranean-type climate of Western Cape Province of South ...
... New Rochelle, NY, March 17, 2011A new research tool ... study the effects of miRNA on the early development ... disease mechanisms in humans, as described in Zebrafish, ... Inc. The article is available free online ahead of ...
... waste decaying down at the dump needs millions of years ... reactors, could pose an especially serious health risk should it ... years after its deposition. Now, researchers at the University of ... contained. The means? A particular kind of green goop that ...
Cached Biology News:Optimizing yield and fruit size of figs 2Green sludge can protect groundwater from radioactive contamination 2
... protein array systems, known as ChemiArrayTM ... useful compared with current methodologies. Besides ... Chemicons systems present a more accurate ... they only detect secreted cytokines, and ...
... The Easy Cap tool provides ... seat domed double-locking caps in tubes ... has a wide end that firmly ... prevent accidental crushing when opening or ...
... USP is a highly nutritious versatile medium ... Due to the inclusion of both Tryptone ... growth of many fastidious organisms without the ... to United States Pharmacopeia standards for use ...
...
Biology Products: